Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine vs Tramadol for Post-Op Pain in Pediatric Cancer
NCT07110051Recruiting
- Sponsor
- National Cancer Institute
- Start
- Jan 2025
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial in postoperative pain comparing Nalbuphine with Tramadol (2 arms). Primary endpoint: Time to first rescue analgesia at 72 hours. Started Jan 2025; status: recruiting.
02
Drugs
nalbuphinetramadol
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07110051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07110051.